Market Samachar
Home  ›  GLOBAL
FIERCEBIOTECH · GLOBAL ·

Lilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profile - Fierce Biotech

As reported by FierceBiotech
As Eli Lilly looks to hold its lead in the lucrative obesity market, the company’s next-gen prospect, the triple-G drug retatrutide, has met the primary endpoint for weight loss in anothe | As Eli Lilly looks to hold its lead in the lucrative obesity market, …
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on FierceBiotech ↗

Market Samachar is a news aggregator. This article was originally published by FierceBiotech. Tap the button above to read the full story on their site.

▸ EXPLORE MARKET SAMACHAR
Free tools for Indian retail investors — all built by us
📈Paper Trading

Trade NSE stocks with virtual coins. Build a portfolio, climb the leaderboard — zero real money.

Start trading ↗
🧠Quiz Master

1,500+ Indian market quiz questions. Earn coins per correct answer, climb leagues, build streaks.

Play now ↗
📊Market Move

Live gainers · losers · FII/DII · MTF · News Buzz. The complete Indian market dashboard.

View dashboard ↗
Pulse

Swipe BULL or BEAR on today's news. Earn +5 coins per swipe, +20 bonus when you're right.

Start swiping ↗

More from Market Samachar